SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-4 - Registration of securities, business combinations:
SEC Accession No. 0001213900-21-044765
Filing Date
2021-08-25
Accepted
2021-08-25 15:21:34
Documents
142

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs42021_cmlifesci3.htm   iXBRL S-4 14558179
2 EQRX 2019 STOCK OPTION AND GRANT PLAN fs42021ex10-3_cmlifescien3.htm EX-10.3 130024
3 EQRX, INC. FORM OF EMPLOYEE CONFIDENTIALITY, ASSIGNMENT AND NON-SOLICITATION AGR fs42021ex10-11_cmlifescien3.htm EX-10.11 45682
4 AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT fs42021ex10-32_cmlifescien3.htm EX-10.32 184297
5 CONSENT OF WITHUMSMITH+BROWN, PC fs42021ex23-1_cmlifescien3.htm EX-23.1 1877
6 CONSENT OF ERNST & YOUNG LLP fs42021ex23-2_cmlifescien3.htm EX-23.2 1799
7 CONSENT OF PAUL BERNS TO BE NAMED AS A DIRECTOR fs42021ex99-2_cmlifescien3.htm EX-99.2 2879
8 CONSENT OF ALEXIS BORISY TO BE NAMED AS A DIRECTOR fs42021ex99-3_cmlifescien3.htm EX-99.3 2845
9 CONSENT OF JORGE CONDE TO BE NAMED AS A DIRECTOR fs42021ex99-4_cmlifescien3.htm EX-99.4 2839
10 CONSENT OF SANDRA HORNING TO BE NAMED AS A DIRECTOR fs42021ex99-5_cmlifescien3.htm EX-99.5 2849
11 CONSENT OF CLIVE MEANWELL TO BE NAMED AS A DIRECTOR fs42021ex99-6_cmlifescien3.htm EX-99.6 2866
12 CONSENT OF SAM MERKSAMER TO BE NAMED AS A DIRECTOR fs42021ex99-7_cmlifescien3.htm EX-99.7 2847
13 CONSENT OF MELANIE NALLICHERI TO BE NAMED AS A DIRECTOR fs42021ex99-8_cmlifescien3.htm EX-99.8 2877
14 CONSENT OF KRISHNA YESHWANT TO BE NAMED AS A DIRECTOR fs42021ex99-9_cmlifescien3.htm EX-99.9 2871
15 CONSENT OF HOULIHAN LOUKEY CAPITAL, INC. fs42021ex99-10_cmlifescien3.htm EX-99.10 6205
16 GRAPHIC teqrx_logo.jpg GRAPHIC 702720
17 GRAPHIC teqrx_logored.jpg GRAPHIC 706221
18 GRAPHIC teqrx_red.jpg GRAPHIC 681777
19 GRAPHIC teqrxstand_001.jpg GRAPHIC 1004746
20 GRAPHIC tglance_001.jpg GRAPHIC 1484773
21 GRAPHIC timage_001.jpg GRAPHIC 278894
22 GRAPHIC timage_002.jpg GRAPHIC 605573
23 GRAPHIC timage_003.jpg GRAPHIC 585535
24 GRAPHIC timage_004.jpg GRAPHIC 503201
25 GRAPHIC timage_005.jpg GRAPHIC 2184803
26 GRAPHIC timage_006.jpg GRAPHIC 518500
27 GRAPHIC timage_007.jpg GRAPHIC 452546
28 GRAPHIC timage_008.jpg GRAPHIC 378777
29 GRAPHIC timage_009.jpg GRAPHIC 451082
30 GRAPHIC timage_010.jpg GRAPHIC 629346
31 GRAPHIC timage_011.jpg GRAPHIC 600409
32 GRAPHIC timage_012.jpg GRAPHIC 593799
33 GRAPHIC tletter_001.jpg GRAPHIC 197583
34 GRAPHIC tmission_001.jpg GRAPHIC 1420356
  Complete submission text file 0001213900-21-044765.txt   60934419

Data Files

Seq Description Document Type Size
35 XBRL SCHEMA FILE cmlt-20210630.xsd EX-101.SCH 148574
36 XBRL CALCULATION FILE cmlt-20210630_cal.xml EX-101.CAL 37427
37 XBRL DEFINITION FILE cmlt-20210630_def.xml EX-101.DEF 659003
38 XBRL LABEL FILE cmlt-20210630_lab.xml EX-101.LAB 913307
39 XBRL PRESENTATION FILE cmlt-20210630_pre.xml EX-101.PRE 644313
40 EXTRACTED XBRL INSTANCE DOCUMENT fs42021_cmlifesci3_htm.xml XML 3812587
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065 (212) 474 6724
CM Life Sciences III Inc. (Filer) CIK: 0001843762 (see all company filings)

IRS No.: 861691173 | Fiscal Year End: 1231
Type: S-4 | Act: 33 | File No.: 333-259054 | Film No.: 211206295
SIC: 6770 Blank Checks